Gentle Pro Hospice Services Inc 2060 E Algonquin Road Suite 701, Schaumburg, IL, 60173 | |
(847) 228-9481 |
News Archive
Flagship Services Group, Inc., a company providing expertise in Medicare compliance for insurance carriers, self-insured entities, attorneys, and state and local government agencies, today announced its unique end-to-end solutions for the compliance challenges the industry faces relating to the Centers for Medicare and Medicaid Services' reporting and Medicare Secondary Payer recovery requirements.
Avinger, Inc., a medical device company focused on the development of innovative devices to combat peripheral artery disease, announces the enrollment of the first patient in the CONNECT (Chronic TOtal OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial. The CONNECT trial is a prospective, multi-center, non-randomized study intended to evaluate the Wildcat Catheter's ability to cross chronic total occlusions in femoropopliteal lesions.
"Why didn't you order test X?" That question, posed routinely to residents by faculty members at teaching hospitals, bears some of the blame for the high and unsustainable cost of U.S. health care, writes a leader of the American College of Physicians in the September 20 issue of the Annals of Internal Medicine.
"As health insurers release earnings starting this week, the focus will likely be on clues as to how the U.S. health overhaul affects margins and growth," Dow Jones Newswires/The Wall Street Journal reports. "Led by managed-care bellwether UnitedHealth Group Inc. (UNH), the sector is seen posting hardy earnings for the second quarter.
› Verified 8 days ago
Name | Gentle Pro Hospice Services Inc |
---|---|
Location | 2060 E Algonquin Road Suite 701, Schaumburg, Illinois |
Hospice ID | 141613 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
SSA county code | 141 |
News Archive
Flagship Services Group, Inc., a company providing expertise in Medicare compliance for insurance carriers, self-insured entities, attorneys, and state and local government agencies, today announced its unique end-to-end solutions for the compliance challenges the industry faces relating to the Centers for Medicare and Medicaid Services' reporting and Medicare Secondary Payer recovery requirements.
Avinger, Inc., a medical device company focused on the development of innovative devices to combat peripheral artery disease, announces the enrollment of the first patient in the CONNECT (Chronic TOtal OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial. The CONNECT trial is a prospective, multi-center, non-randomized study intended to evaluate the Wildcat Catheter's ability to cross chronic total occlusions in femoropopliteal lesions.
"Why didn't you order test X?" That question, posed routinely to residents by faculty members at teaching hospitals, bears some of the blame for the high and unsustainable cost of U.S. health care, writes a leader of the American College of Physicians in the September 20 issue of the Annals of Internal Medicine.
"As health insurers release earnings starting this week, the focus will likely be on clues as to how the U.S. health overhaul affects margins and growth," Dow Jones Newswires/The Wall Street Journal reports. "Led by managed-care bellwether UnitedHealth Group Inc. (UNH), the sector is seen posting hardy earnings for the second quarter.
› Verified 8 days ago
NPI Number | 1821153057 |
Organization Name | Gentlepro Hospice Services Corp |
Address | 2060 E Algonquin Rd Schaumburg, Illinois, 60173 |
Phone Number | (847)228-9481 |
News Archive
Flagship Services Group, Inc., a company providing expertise in Medicare compliance for insurance carriers, self-insured entities, attorneys, and state and local government agencies, today announced its unique end-to-end solutions for the compliance challenges the industry faces relating to the Centers for Medicare and Medicaid Services' reporting and Medicare Secondary Payer recovery requirements.
Avinger, Inc., a medical device company focused on the development of innovative devices to combat peripheral artery disease, announces the enrollment of the first patient in the CONNECT (Chronic TOtal OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial. The CONNECT trial is a prospective, multi-center, non-randomized study intended to evaluate the Wildcat Catheter's ability to cross chronic total occlusions in femoropopliteal lesions.
"Why didn't you order test X?" That question, posed routinely to residents by faculty members at teaching hospitals, bears some of the blame for the high and unsustainable cost of U.S. health care, writes a leader of the American College of Physicians in the September 20 issue of the Annals of Internal Medicine.
"As health insurers release earnings starting this week, the focus will likely be on clues as to how the U.S. health overhaul affects margins and growth," Dow Jones Newswires/The Wall Street Journal reports. "Led by managed-care bellwether UnitedHealth Group Inc. (UNH), the sector is seen posting hardy earnings for the second quarter.
› Verified 8 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Flagship Services Group, Inc., a company providing expertise in Medicare compliance for insurance carriers, self-insured entities, attorneys, and state and local government agencies, today announced its unique end-to-end solutions for the compliance challenges the industry faces relating to the Centers for Medicare and Medicaid Services' reporting and Medicare Secondary Payer recovery requirements.
Avinger, Inc., a medical device company focused on the development of innovative devices to combat peripheral artery disease, announces the enrollment of the first patient in the CONNECT (Chronic TOtal OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial. The CONNECT trial is a prospective, multi-center, non-randomized study intended to evaluate the Wildcat Catheter's ability to cross chronic total occlusions in femoropopliteal lesions.
"Why didn't you order test X?" That question, posed routinely to residents by faculty members at teaching hospitals, bears some of the blame for the high and unsustainable cost of U.S. health care, writes a leader of the American College of Physicians in the September 20 issue of the Annals of Internal Medicine.
"As health insurers release earnings starting this week, the focus will likely be on clues as to how the U.S. health overhaul affects margins and growth," Dow Jones Newswires/The Wall Street Journal reports. "Led by managed-care bellwether UnitedHealth Group Inc. (UNH), the sector is seen posting hardy earnings for the second quarter.
› Verified 8 days ago
Home Health Aides | 4 |
Counselors | 1 |
Homemakers | 3 |
Licensed Practical or Vocational Nurses | 2 |
Medical Social Workers | 1 |
Physicians | 1 |
Registered Nurses | 6 |
Total Employees | 18 |
---|
News Archive
Flagship Services Group, Inc., a company providing expertise in Medicare compliance for insurance carriers, self-insured entities, attorneys, and state and local government agencies, today announced its unique end-to-end solutions for the compliance challenges the industry faces relating to the Centers for Medicare and Medicaid Services' reporting and Medicare Secondary Payer recovery requirements.
Avinger, Inc., a medical device company focused on the development of innovative devices to combat peripheral artery disease, announces the enrollment of the first patient in the CONNECT (Chronic TOtal OcclusioN CrossiNg with thE WildCat CatheTer) clinical trial. The CONNECT trial is a prospective, multi-center, non-randomized study intended to evaluate the Wildcat Catheter's ability to cross chronic total occlusions in femoropopliteal lesions.
"Why didn't you order test X?" That question, posed routinely to residents by faculty members at teaching hospitals, bears some of the blame for the high and unsustainable cost of U.S. health care, writes a leader of the American College of Physicians in the September 20 issue of the Annals of Internal Medicine.
"As health insurers release earnings starting this week, the focus will likely be on clues as to how the U.S. health overhaul affects margins and growth," Dow Jones Newswires/The Wall Street Journal reports. "Led by managed-care bellwether UnitedHealth Group Inc. (UNH), the sector is seen posting hardy earnings for the second quarter.
› Verified 8 days ago
Gentle Pro Hospice Services Inc Location: 2060 E Algonquin Road Suite 701, Schaumburg, Illinois, 60173 Phone: (847) 228-9481 |
Abode Hospice Care Location: 1325 Remington Rd Suite L, Schaumburg, Illinois, 60173 Phone: (847) 228-9481 |